These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1852896)

  • 61. Prostaglandin (PG) E1 and 13,14-dihydro (DH) PGE1 are diminishing radiation-induced arterial damage.
    Neumann I; Rogatti W; Virgolini I; Firbas W; Sinzinger H
    Agents Actions Suppl; 1992; 37():58-65. PubMed ID: 1632312
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effects of prostaglandin E1 infusion during cardiopulmonary bypass].
    Okuda M; Ohi Y; Utsunomiya H; Kurata M; Konishi K; Muneyuki M
    Masui; 1989 Aug; 38(8):1036-41. PubMed ID: 2810697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2.
    Förstermann U; Neufang B
    J Pharm Pharmacol; 1983 Nov; 35(11):724-8. PubMed ID: 6139453
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man.
    Ney P; Braun M; Szymanski C; Bruch L; Schrör K
    Eicosanoids; 1991; 4(3):177-84. PubMed ID: 1663381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 9-Hydroxyprostaglandin dehydrogenase in rat kidney cortex converts prostaglandin I2 into 15-keto-13,14-dihydro 6-ketoprostaglandin E1.
    Pace-Asciak CR; Domazet Z
    Biochim Biophys Acta; 1984 Nov; 796(2):129-35. PubMed ID: 6388642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
    Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
    Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy].
    Nakayama M; Kanaya N; Fujita S; Kawana S; Namiki A
    Masui; 1995 Sep; 44(9):1224-7. PubMed ID: 8523654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacologically active levels of PGE1 in neonates with congenital heart disease.
    Leonhardt A; Kühl PG; Schweer H; Wolf D; Seyberth HW
    Acta Paediatr Scand; 1989 Nov; 78(6):853-7. PubMed ID: 2603710
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prostaglandin E1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular disease.
    Palumbo B; Oguogho A; Fitscha P; Sinzinger H
    Vasa; 2000 Aug; 29(3):179-85. PubMed ID: 11037715
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Placental vascular responses to 6-keto-prostaglandin E1 in the near-term sheep.
    Schwartz DB; Phernetton TM; Stock MK; Rankin JH
    Am J Obstet Gynecol; 1983 Feb; 145(4):406-10. PubMed ID: 6337494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of intravenous prostaglandin E1 on experimental flaps.
    Suzuki S; Isshiki N; Ogawa Y; Nishimura R; Kurokawa M
    Ann Plast Surg; 1987 Jul; 19(1):49-53. PubMed ID: 3631860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep.
    Ogletree ML; Brigham KL
    Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of prostaglandin E1 on the renin-aldosterone system in patients with diabetic nephropathy.
    Okada S; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1993; 21(3):126-32. PubMed ID: 8299855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The effect of low-rose prostaglandin E1 on circulation, respiration and body temperature during surgical anesthesia].
    Hayashida M; Hanaoka K; Shimada Y; Namiki A; Amaha K
    Masui; 1997 Mar; 46(3):363-72. PubMed ID: 9095609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
    Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion.
    Kato T; Sato T; Kurokawa T; Nanjo H; Asanuma Y; Koyama K
    Transplantation; 2003 Nov; 76(9):1340-5. PubMed ID: 14627913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
    Schellong SM; Burchert W; Böger RM; Creutzig A; Hundeshagen H; Alexander K
    Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.